For research use only. Not for therapeutic Use.
<span style="color:#000000;"><span style="font-size: 12px; font-family: arial, helvetica, sans-serif;">2' 3'-DIDEOXYADENOSINE 5'-TRIPHOSPHATE S(CAS 178451-61-1;ddATP) is an <em>in vitro</em> inhibitor of reverse transcriptases from retroviruses, including HIV-1 and visna (K<span style="box-sizing: border-box; position: relative; line-height: 0; vertical-align: initial; bottom: -0.25em;">i</span>s = 20 and 37 nM, respectively).It also blocks, <em>in vitro</em>, mammalian and bacterial DNA polymerases. ddATP, produced intracellularly by the phosphorylation of exogenously supplied 2’,3’-dideoxyadenosine, competes with dATP, resulting in chain termination.Because of this activity, dideoxynucleoside 5’-triphosphates, including ddATP, are used to terminate chain extension produced by the Taq</span><font face="arial, helvetica, sans-serif"> polymerase used in polymerase chain reactions. It is also an antagonist of the purinergic receptor P2X</font><span style="font-family: arial, helvetica, sans-serif; font-size: 12px; box-sizing: border-box; position: relative; line-height: 0; vertical-align: initial; bottom: -0.25em;">2/3</span><font face="arial, helvetica, sans-serif"> (pIC</font><span style="font-family: arial, helvetica, sans-serif; font-size: 12px; box-sizing: border-box; position: relative; line-height: 0; vertical-align: initial; bottom: -0.25em;">50</span><font face="arial, helvetica, sans-serif"> = 6.5).</font></span>
Catalog Number | M045583 |
CAS Number | 178451-61-1 |
Molecular Formula | C10H12N5Na4O11P3 |
Purity | ≥95% |
Storage | Desiccate at -20C |
Reference | 1.<span style="font-family: Arial, sans-serif; font-size: 13px;">Boyle, Nicholas A., et al. "Synthesis of 2 ‘, 3 ‘-Dideoxynucleoside 5 ‘-α-P-Borano-β, γ-(difluoromethylene) triphosphates and Their Inhibition of HIV-1 Reverse Transcriptase." </span><i style="font-family: Arial, sans-serif; font-size: 13px;">Journal of medicinal chemistry</i><span style="font-family: Arial, sans-serif; font-size: 13px;"> 48.7 (2005): 2695-2700.<br /> |